Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E

Contact Research Centre

Chronic graft versus host disease

Not recruiting

InvestigationalNo placebo

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Hormone-refractory prostate cancer

Not recruiting

Registered drugNo placebo

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Hyponatraemia

Not recruiting

Registered drug

Study on the Effects of Empagliflozin in Patients with Euvolemic and Hypervolemic Hyponatremia

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Primary amyloidosis

Not recruiting

InvestigationalNo placebo

Study of Teclistamab for Patients with Previously Treated AL Amyloidosis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin

Contact Research Centre

Fabry's disease

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Isaralgagene Civaparvovec

Contact Research Centre

Skin ulcer

Not recruiting

Investigational

Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:RO7284755

Contact Research Centre

Prophylaxis of nausea and vomiting

Not recruiting

Registered drugNo placebo

Study on Amisulpride, Dexamethasone Phosphate, and Ondansetron for Preventing Post-Operative Nausea and Vomiting in Children

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Amisulpride

Contact Research Centre

Find therapies in clinical trials near you – page 21

445 trials match your criteria

Cardiac amyloidosis

Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Small cell lung cancer

Study of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules

Respiratory syncytial virus infection+3

Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

Chronic graft versus host disease

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

Hormone-refractory prostate cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Hyponatraemia

Study on the Effects of Empagliflozin in Patients with Euvolemic and Hypervolemic Hyponatremia

Primary amyloidosis

Study of Teclistamab for Patients with Previously Treated AL Amyloidosis

Plasma cell myeloma

Study Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

Fabry's disease

Long-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease

Skin ulcer

Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

Bladder transitional cell carcinoma

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Prophylaxis of nausea and vomiting

Study on Amisulpride, Dexamethasone Phosphate, and Ondansetron for Preventing Post-Operative Nausea and Vomiting in Children

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.